Fields »
ABOUT
HELP
BLOG

675 GENES FOUND

Show / hide columns

XML | RDF | TSV | « prev | Page of 14 | next »

Gene

 

 

Gene description

x

 

 

 

 

 

 

 

Tissue

Cell

Pathology

 

 

 

 

IH abundance (Normal Tissue)

x

RNA abundance (Normal Tissue)

x

Subcellular location

x

Prognostic p-value

x

 

RNA tissue category

x

RNA TS

x

RNA TS TPM

x

 

 

 

 

 

 

 

 

 

 

 

 

 

 
APOL1Apolipoprotein L, 1
Renal cancer: 7.43e-6
Urothelial cancer: 2.01e-5
Lung cancer: 5.35e-4
Expressed in all
ARSEArylsulfatase E (chondrodysplasia punctata 1)
Golgi apparatusColorectal cancer: 8.95e-4
Tissue enhancedkidney:41.1
liver:49.1
ART3ADP-ribosyltransferase 3
Tissue enhancedskeletal muscle:77.0
testis:173.4
ART4ADP-ribosyltransferase 4 (Dombrock blood group)
Rods & RingsTissue enhancedliver:27.1
spleen:27.3
ATP13A1ATPase type 13A1
VesiclesRenal cancer: 6.51e-4
Expressed in all
ATP5F1ATP synthase, H+ transporting, mitochondrial Fo complex, subunit B1
Nucleoplasm
Mitochondria		Renal cancer: 3.26e-9
Stomach cancer: 8.07e-4
Expressed in all
ATP6AP1ATPase, H+ transporting, lysosomal accessory protein 1
Plasma membrane
Microtubules
Cytosol		Renal cancer: 5.26e-8
Breast cancer: 2.40e-4
Glioma: 7.82e-4
Pancreatic cancer: 7.83e-4
Expressed in all
ATP6AP2ATPase, H+ transporting, lysosomal accessory protein 2
Renal cancer: 2.01e-5
Expressed in all
BACE2Beta-site APP-cleaving enzyme 2
Cervical cancer: 1.11e-4
Glioma: 8.13e-4
Mixed
BCAMBasal cell adhesion molecule (Lutheran blood group)
Nucleoli fibrillar centerRenal cancer: 5.94e-6
Endometrial cancer: 1.24e-5
Colorectal cancer: 2.31e-4
Expressed in all
BCAP29B-cell receptor-associated protein 29
CytosolLiver cancer: 3.62e-4
Expressed in all
BDNFBrain-derived neurotrophic factor
Nuclear speckles
Mitochondria		Tissue enhancedcerebral cortex:12.0
BOCBOC cell adhesion associated, oncogene regulated
Nucleoplasm
Plasma membrane		Urothelial cancer: 1.18e-5
Head and neck cancer: 4.89e-4
Mixed
BPIBactericidal/permeability-increasing protein
Tissue enriched36bone marrow:963.1
BSGBasigin (Ok blood group)
VesiclesRenal cancer: 1.95e-6
Liver cancer: 5.48e-6
Endometrial cancer: 2.59e-4
Expressed in all
BTN2A2Butyrophilin, subfamily 2, member A2
MitochondriaBreast cancer: 1.01e-4
Mixed
BTN3A1Butyrophilin, subfamily 3, member A1
VesiclesRenal cancer: 4.15e-5
Urothelial cancer: 4.81e-4
Expressed in all
BTN3A2Butyrophilin, subfamily 3, member A2
Renal cancer: 4.24e-4
Expressed in all
BTN3A3Butyrophilin, subfamily 3, member A3
Renal cancer: 2.42e-5
Ovarian cancer: 1.80e-4
Mixed
C11orf24Chromosome 11 open reading frame 24
Nucleoplasm
Vesicles		Renal cancer: 1.60e-9
Lung cancer: 6.05e-4
Glioma: 9.83e-4
Expressed in all
C12orf76Chromosome 12 open reading frame 76
Plasma membrane
Actin filaments		Renal cancer: 5.74e-5
Lung cancer: 6.44e-5
Expressed in all
C1orf159Chromosome 1 open reading frame 159
Nucleoli fibrillar center
Cytosol		Renal cancer: 1.77e-6
Liver cancer: 9.58e-6
Urothelial cancer: 1.62e-4
Mixed
C3orf33Chromosome 3 open reading frame 33
Nucleoplasm
Cytosol		Renal cancer: 6.48e-7
Mixed
C6orf25Chromosome 6 open reading frame 25
Golgi apparatusNot detected
CA9Carbonic anhydrase IX
Plasma membrane
Cytosol		Renal cancer: 2.22e-7
Liver cancer: 1.71e-5
Testis cancer: 9.50e-4
Tissue enhancedgallbladder:36.1
stomach:92.4
CACNA2D1Calcium channel, voltage-dependent, alpha 2/delta subunit 1
Renal cancer: 1.16e-4
Mixed
CACNA2D4Calcium channel, voltage-dependent, alpha 2/delta subunit 4
Not detected
CADM3Cell adhesion molecule 3
Renal cancer: 1.03e-5
Urothelial cancer: 5.75e-4
Tissue enhancedcerebral cortex:279.4
placenta:113.9
CALCRCalcitonin receptorN/A
Tissue enhancedkidney:2.1
testis:1.4
CALCRLCalcitonin receptor-like
Plasma membraneTissue enhancedlung:114.4
CAMK2DCalcium/calmodulin-dependent protein kinase II delta
Plasma membrane
Cell Junctions		Expressed in all
CANXCalnexin
Endoplasmic reticulumColorectal cancer: 1.38e-4
Thyroid cancer: 3.17e-4
Expressed in all
CATSPERGCatsper channel auxiliary subunit gamma
Nucleus
Nucleoli
Cytosol		Tissue enriched41testis:48.5
CCL5Chemokine (C-C motif) ligand 5
Renal cancer: 3.61e-7
Endometrial cancer: 1.34e-5
Melanoma: 2.42e-4
Tissue enhancedspleen:81.8
CCL7Chemokine (C-C motif) ligand 7
Group enriched8appendix:3.6
bone marrow:15.3
CD164CD164 molecule, sialomucin
Expressed in all
CD1ECD1e molecule
Tissue enhancedskin:18.3
CD2CD2 molecule
Renal cancer: 4.82e-6
Endometrial cancer: 1.69e-5
Melanoma: 3.97e-5
Head and neck cancer: 7.46e-5
Cervical cancer: 1.47e-4
Breast cancer: 4.36e-4
Ovarian cancer: 7.72e-4
Tissue enhancedlymph node:132.9
CD200CD200 molecule
Mixed
CD200R1CD200 receptor 1
Tissue enhancedspleen:14.7
CD22CD22 molecule
Tissue enhancedlymph node:269.3
ovary:163.3
spleen:155.4
tonsil:219.0
CD226CD226 molecule
Tissue enriched11parathyroid gland:312.4
CD276CD276 molecule
VesiclesRenal cancer: 6.31e-5
Liver cancer: 9.81e-4
Mixed
CD300ACD300a molecule
Renal cancer: 1.91e-5
Tissue enhancedspleen:87.2
CD300LBCD300 molecule-like family member b
Tissue enhancedappendix:11.7
CD300LFCD300 molecule-like family member f
Tissue enhancedlung:25.6
spleen:28.6
CD300LGCD300 molecule-like family member g
Group enriched5adipose tissue:142.8
placenta:85.6
testis:33.9
CD3DCD3d molecule, delta (CD3-TCR complex)
Endometrial cancer: 1.73e-7
Renal cancer: 3.07e-5
Cervical cancer: 8.46e-5
Head and neck cancer: 1.70e-4
Breast cancer: 3.00e-4
Urothelial cancer: 6.16e-4
Tissue enhancedlymph node:202.6
tonsil:124.1
CD4CD4 molecule
Plasma membraneEndometrial cancer: 2.16e-4
Renal cancer: 7.45e-4
Tissue enhancedparathyroid gland:538.7
CD40CD40 molecule, TNF receptor superfamily member 5
Renal cancer: 4.48e-4
Expressed in all

« prev | Page of 14 | next »

Contact

The Project

The Human Protein Atlas

The Human Protein Atlas project is funded
by the Knut & Alice Wallenberg foundation.